KOWA PHARMACEUTICAL EUROPE CO. LTD.
Get an alert when KOWA PHARMACEUTICAL EUROPE CO. LTD. files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-07-12 (in 2mo)
Last made up 2025-06-28
Watchouts
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
Accounts
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In addition to a profit for the year of £3.5m the company had net current assets of £17.8m as at 31 December 2024. These financial statements have been prepared on a going concern basis which the directors consider to be appropriate for the following reasons. The directors have prepared cash flow forecasts for a period of 12 months from the date of approval of these financial statements which indicate that, taking account of reasonably possible downsides including the ongoing political uncertainty from Europe, the Middle East and more recently the USA, due to challenges in supply chain, low/volatile exchange rates, the company will have sufficient funds to meet its liabilities as they fall due for that period. Consequently, the directors are confident that the company will have sufficient funds to continue to meet its liabilities as they fall due for at least 12 months from the date of approval of the financial statements and therefore have prepared the financial statements on a going concern basis.”
Significant events
- “The IOL business was sold on 30th September 2024 to a newly created sister company Kowa Medical Care Europe GmbH.”
- “From April 2024, purchase contracts denomination was changed from JPY to EUR, significantly reducing foreign exchange risk.”
- “The Company has entered into a new agreement to supply active ingredients Pitavastatin and Ezetimibe for product K-924 in the Middle East region, with the initial upfront license fee recognized in 2024.”
- “The Pitava trademark was approved in Greece in early 2025 resolving the trademark dispute.”
- “In early May 2025, the ultimate parent company requested the Company withdraw €11m cash from the Euro short term deposit account to loan this to another group company.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 32 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LDC NOMINEE SECRETARY LIMITED | Corporate Secretary | 2021-02-01 | — | — |
| EDAMATSU, Tadashi | Director | 2025-07-14 | Feb 1970 | Japanese |
| KANDA, Toshio | Director | 2020-07-01 | Sep 1973 | Japanese |
| KANEZASHI, Yoshihisa | Director | 2023-08-16 | Sep 1975 | Japanese |
| KAWAGOE, Junichi | Director | 2025-07-14 | Jan 1964 | Japanese |
| SHIGENAKA, Masataka | Director | 2024-10-01 | Oct 1972 | Japanese |
Show 32 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| EVERSECRETARY LIMITED | Corporate Secretary | 2005-04-01 | 2021-02-01 |
| EXCELLET INVESTMENTS LIMITED | Corporate Secretary | 2000-09-26 | 2005-04-01 |
| HALLMARK SECRETARIES LIMITED | Corporate Nominee Secretary | 2000-09-26 | 2000-09-26 |
| COOMBS, Roderick Joseph, Dr | Director | 2012-11-15 | 2025-03-31 |
| INAZU, Yuji | Director | 2020-07-01 | 2021-06-29 |
| INOUE, Yoshiro | Director | 2001-10-25 | 2004-05-28 |
| IRELAND, Robert | Director | 2001-10-25 | 2011-05-23 |
| KASHIO, Kazuaki | Director | 2021-06-29 | 2024-01-16 |
| KAWAGOE, Junichi, Dr | Director | 2006-08-16 | 2020-07-01 |
| KIMURA, Shigeru | Director | 2019-07-01 | 2021-06-29 |
| KINOUCHI, Hitoshi | Director | 2019-07-01 | 2025-07-14 |
| KUGA, Hiroshi | Director | 2009-06-26 | 2011-05-23 |
| KUGA, Hiroshi | Director | 2004-05-28 | 2006-08-14 |
| MIWA, Naoki | Director | 2023-01-09 | 2025-07-14 |
| MIWA, Yoshihiro | Director | 2000-12-18 | 2004-05-28 |
| MORIBE, Mutsumi | Director | 2014-10-01 | 2017-06-29 |
| NAGASHIMA, Takahiko | Director | 2011-05-23 | 2012-11-15 |
| NARUSAWA, Takashi | Director | 2016-03-24 | 2019-07-01 |
| OGAWA, Michiyuki | Director | 2000-09-26 | 2001-10-25 |
| PARIS, Drummond | Director | 2006-08-16 | 2013-12-11 |
| PICARD, Gilles | Director | 2014-04-01 | 2015-04-14 |
| SAKAI, Hideki | Director | 2000-09-26 | 2009-06-26 |
| SHIRAISHI, Koichi | Director | 2009-06-26 | 2019-07-01 |
| TAGASHIRA, Yasuhiro | Director | 2004-05-28 | 2006-08-14 |
| TAMURA, Koji | Director | 2011-05-23 | 2012-11-15 |
| TANABE, Sohei, Dr | Director | 2017-06-29 | 2019-07-01 |
| TOBITA, Takashi | Director | 2019-07-01 | 2020-07-01 |
| YAMAMOTO, Torao | Director | 2000-09-26 | 2015-07-01 |
| YAMASHITA, Koji | Director | 2014-10-01 | 2017-06-29 |
| ZAAT, Ralph Antonius, Dr | Director | 2016-03-24 | 2024-01-16 |
| HALLMARK REGISTRARS LIMITED | Corporate Nominee Director | 2000-09-26 | 2000-09-26 |
| QUICKNESS LIMITED | Corporate Director | 2000-09-26 | 2000-09-26 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Yoshihiro Miwa | Individual | Significant influence | 2016-04-06 | Ceased 2025-06-11 |
Filing timeline
Last 20 of 152 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-07-29 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-23 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-23 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-23 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-23 | CH01 | officers | Change person director company with change date | |
| 2025-07-22 | AD02 | address | Change sail address company with old address new address | |
| 2025-07-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-18 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2025-06-11 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2025-06-05 | AA | accounts | Accounts with accounts type full | |
| 2025-04-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-02 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-23 | AA | accounts | Accounts with accounts type full | |
| 2024-07-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-06-25 | CH01 | officers | Change person director company with change date | |
| 2024-02-20 | TM01 | officers | Termination director company with name termination date | |
| 2024-02-20 | TM01 | officers | Termination director company with name termination date | |
| 2023-08-30 | AD04 | address | Move registers to registered office company with new address | |
| 2023-08-24 | AP01 | officers | Appoint person director company with name date | |
| 2023-07-12 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 10
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
Latest filed period vs the prior one